Literature DB >> 14654372

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium.

Arnoud C Fijnvandraat1, Antoni C G van Ginneken, Cees A Schumacher, Kenneth R Boheler, Ronald H Lekanne Deprez, Vincent M Christoffels, Antoon F M Moorman.   

Abstract

Mouse embryonic stem (ES) cells easily differentiate towards the cardiac lineage making them suitable as an in vitro model to study cardiogenesis and as a potential source of transplantable cells. In this study, we show by in situ hybridisation that about 30% of the volume of cultures of differentiating ES cells consists of cardiomyocytes. RT-PCR analyses showed that the transcription factors Nkx2.5, Gata4, Mef2c and Irx4 were expressed at levels in the same order of magnitude as the levels observed in embryonic, neonatal and adult hearts. Atrial natriuretic factor and Connexin 40, associated with chamber formation in vivo, are expressed at relatively low levels, similar to those observed at early heart development in vivo. To facilitate the isolation of ES cell-derived cardiomyocytes, a cell line was constructed by stable transfection of the aminoglycoside phosphotransferase cDNA driven by the cardiac-specific distant upstream part of the Na(+)/Ca(2+) exchanger promoter. To accomplish single-copy integration, the construct was inserted into the hypoxanthine phosphoribosyltransferase locus of HM1 ES cells by homologous recombination. Cardiac-specific resistance to G418-sulphate (neomycin) allowed isolation of a pure population of cardiomyocytes. Genetically selected and unselected cell populations were characterised electrophysiologically using patch clamp. To explore whether clusters of cells have a similar differentiation profile, action potentials (APs) were measured in aggregates of differentiating ES cells, using a new method based on the voltage-dependent fluorescent dye di-4-ANEPPS. Both whole-cell recordings using patch-clamp and optical measurements with di-4-ANEPPS of the AP showed that upstroke velocity increases and AP duration decreases with differentiation time, accompanied by a decrease in AP interval, suggesting the initiation of the developmental programme underlying the formation of chamber myocardium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654372     DOI: 10.1016/j.yjmcc.2003.09.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  27 in total

Review 1.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

2.  FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.

Authors:  Nathalie Rosenblatt-Velin; Mario G Lepore; Cristina Cartoni; Friedrich Beermann; Thierry Pedrazzini
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

Review 3.  Cardiac repair by embryonic stem-derived cells.

Authors:  M Rubart; L J Field
Journal:  Handb Exp Pharmacol       Date:  2006

Review 4.  Heart repair and stem cells.

Authors:  Linda W van Laake; Rutger Hassink; Pieter A Doevendans; Christine Mummery
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

Review 5.  Immune response to stem cells and strategies to induce tolerance.

Authors:  Puspa Batten; Nadia A Rosenthal; Magdi H Yacoub
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

6.  Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes.

Authors:  Valerie F Shimko; William C Claycomb
Journal:  Tissue Eng Part A       Date:  2008-01       Impact factor: 3.845

7.  Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells.

Authors:  Andreas S Barth; Eddy Kizana; Rachel R Smith; John Terrovitis; Peihong Dong; Michelle K Leppo; Yiqiang Zhang; Junichiro Miake; Eric N Olson; Jay W Schneider; M Roselle Abraham; Eduardo Marbán
Journal:  Mol Ther       Date:  2008-03-18       Impact factor: 11.454

8.  Nongenetic method for purifying stem cell-derived cardiomyocytes.

Authors:  Fumiyuki Hattori; Hao Chen; Hiromi Yamashita; Shugo Tohyama; Yu-Suke Satoh; Shinsuke Yuasa; Weizhen Li; Hiroyuki Yamakawa; Tomofumi Tanaka; Takeshi Onitsuka; Kenichiro Shimoji; Yohei Ohno; Toru Egashira; Ruri Kaneda; Mitsushige Murata; Kyoko Hidaka; Takayuki Morisaki; Erika Sasaki; Takeshi Suzuki; Motoaki Sano; Shinji Makino; Shinzo Oikawa; Keiichi Fukuda
Journal:  Nat Methods       Date:  2009-11-29       Impact factor: 28.547

9.  Somatic Cell Reprogramming into Cardiovascular Lineages.

Authors:  Jenny X Chen; Karolina Plonowska; Sean M Wu
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-04-23       Impact factor: 2.457

10.  Cellular cardiomyoplasty and cardiac regeneration.

Authors:  Lakshmana Pendyala; Traci Goodchild; Radhika R Gadesam; Jack Chen; Keith Robinson; Nicolas Chronos; Dongming Hou
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.